Investing Experience -
Risk Profile -
Followers
0
Following
0
Blog Posts
0
Threads
489
Blogs
Threads
Portfolio
Follower
Following
Summary
Total comments
489
Past 30 days
0
Past 7 days
0
Today
0
User Comments
Stock
2020-09-02 12:14 | Report Abuse
这里i3,很少人，不热闹，其实昨天的交易量近100mil ,今天也算多，外面的人们，也许也有收到风会有新业务加入Eastland.
绝对不可能我们几条水，就可以把股价买卖至23 sen的。
Stock
Stock
Stock
2020-09-01 20:55 | Report Abuse
Stock
2020-09-01 20:55 | Report Abuse
Stock
Stock
Stock
2020-09-01 20:50 | Report Abuse
WHY WE LOOK INTO SCOMNET ?
CASH FLOW STRONG.
MEDICAL DIVICE INDUSTRY WILL CONTINUE TO EXHIBIT GOOD GROWTH.
MARGIN INCREASE BECAUSE OF DEVICES BIZ.
ZERO BORROWING.
STRONG & RELIABLE MANAGEMENT.
FAMILY OF HSUEH HOLDED 67.67%.
TWO BIG LISTED CAMPANIES SCOMNET'S 大客户 , EDWARDS LIFE SCIENCE AND AMBU.
刚刚签下不久的另一个大客户，MERMAID MEDICAL，再大大刺激订单，FY2020-FY2021 ！
（独家分销商！）
转至主板可能性非常高！
现金高达RM50 mil ！
零负债！没贷款！
赚副预计从15%至18%！
预料2026年里，心血管设备市场规模会达USD 822 亿！！！
全球由5个主要商参与，其中一个就是SCOMNET的大客户！
FY2020 净利料RM28mil， FY2021 净利RM35 mil！
ON TRACK TO DELIVER RECORD EARNINGS WITH ACCELERATED GROWTH IN EPS OF 59% IN FY2020 & 41% IN fy2021.
STRONG GROWTH CAGR 30%!
Stock
2020-09-01 20:49 | Report Abuse
WHY WE LOOK INTO SCOMNET ?
CASH FLOW STRONG.
MEDICAL DIVICE INDUSTRY WILL CONTINUE TO EXHIBIT GOOD GROWTH.
MARGIN INCREASE BECAUSE OF DEVICES BIZ.
ZERO BORROWING.
STRONG & RELIABLE MANAGEMENT.
FAMILY OF HSUEH HOLDED 67.67%.
TWO BIG LISTED CAMPANIES SCOMNET'S 大客户 , EDWARDS LIFE SCIENCE AND AMBU.
刚刚签下不久的另一个大客户，MERMAID MEDICAL，再大大刺激订单，FY2020-FY2021 ！
（独家分销商！）
转至主板可能性非常高！
现金高达RM50 mil ！
零负债！没贷款！
赚副预计从15%至18%！
预料2026年里，心血管设备市场规模会达USD 822 亿！！！
全球由5个主要商参与，其中一个就是SCOMNET的大客户！
FY2020 净利料RM28mil， FY2021 净利RM35 mil！
ON TRACK TO DELIVER RECORD EARNINGS WITH ACCELERATED GROWTH IN EPS OF 59% IN FY2020 & 41% IN fy2021.
STRONG GROWTH CAGR 30%!
Stock
2020-09-01 20:49 | Report Abuse
WHY WE LOOK INTO SCOMNET ?
CASH FLOW STRONG.
MEDICAL DIVICE INDUSTRY WILL CONTINUE TO EXHIBIT GOOD GROWTH.
MARGIN INCREASE BECAUSE OF DEVICES BIZ.
ZERO BORROWING.
STRONG & RELIABLE MANAGEMENT.
FAMILY OF HSUEH HOLDED 67.67%.
TWO BIG LISTED CAMPANIES SCOMNET'S 大客户 , EDWARDS LIFE SCIENCE AND AMBU.
刚刚签下不久的另一个大客户，MERMAID MEDICAL，再大大刺激订单，FY2020-FY2021 ！
（独家分销商！）
转至主板可能性非常高！
现金高达RM50 mil ！
零负债！没贷款！
赚副预计从15%至18%！
预料2026年里，心血管设备市场规模会达USD 822 亿！！！
全球由5个主要商参与，其中一个就是SCOMNET的大客户！
FY2020 净利料RM28mil， FY2021 净利RM35 mil！
ON TRACK TO DELIVER RECORD EARNINGS WITH ACCELERATED GROWTH IN EPS OF 59% IN FY2020 & 41% IN fy2021.
STRONG GROWTH CAGR 30%!
Stock
2020-09-01 20:48 | Report Abuse
WHY WE LOOK INTO SCOMNET ?
CASH FLOW STRONG.
MEDICAL DIVICE INDUSTRY WILL CONTINUE TO EXHIBIT GOOD GROWTH.
MARGIN INCREASE BECAUSE OF DEVICES BIZ.
ZERO BORROWING.
STRONG & RELIABLE MANAGEMENT.
FAMILY OF HSUEH HOLDED 67.67%.
TWO BIG LISTED CAMPANIES SCOMNET'S 大客户 , EDWARDS LIFE SCIENCE AND AMBU.
刚刚签下不久的另一个大客户，MERMAID MEDICAL，再大大刺激订单，FY2020-FY2021 ！
（独家分销商！）
转至主板可能性非常高！
现金高达RM50 mil ！
零负债！没贷款！
赚副预计从15%至18%！
预料2026年里，心血管设备市场规模会达USD 822 亿！！！
全球由5个主要商参与，其中一个就是SCOMNET的大客户！
FY2020 净利料RM28mil， FY2021 净利RM35 mil！
ON TRACK TO DELIVER RECORD EARNINGS WITH ACCELERATED GROWTH IN EPS OF 59% IN FY2020 & 41% IN fy2021.
STRONG GROWTH CAGR 30%!
Stock
2020-09-01 20:48 | Report Abuse
WHY WE LOOK INTO SCOMNET ?
CASH FLOW STRONG.
MEDICAL DIVICE INDUSTRY WILL CONTINUE TO EXHIBIT GOOD GROWTH.
MARGIN INCREASE BECAUSE OF DEVICES BIZ.
ZERO BORROWING.
STRONG & RELIABLE MANAGEMENT.
FAMILY OF HSUEH HOLDED 67.67%.
TWO BIG LISTED CAMPANIES SCOMNET'S 大客户 , EDWARDS LIFE SCIENCE AND AMBU.
刚刚签下不久的另一个大客户，MERMAID MEDICAL，再大大刺激订单，FY2020-FY2021 ！
（独家分销商！）
转至主板可能性非常高！
现金高达RM50 mil ！
零负债！没贷款！
赚副预计从15%至18%！
预料2026年里，心血管设备市场规模会达USD 822 亿！！！
全球由5个主要商参与，其中一个就是SCOMNET的大客户！
FY2020 净利料RM28mil， FY2021 净利RM35 mil！
ON TRACK TO DELIVER RECORD EARNINGS WITH ACCELERATED GROWTH IN EPS OF 59% IN FY2020 & 41% IN fy2021.
STRONG GROWTH CAGR 30%!
Stock
2020-09-01 20:47 | Report Abuse
WHY WE LOOK INTO SCOMNET ?
CASH FLOW STRONG.
MEDICAL DIVICE INDUSTRY WILL CONTINUE TO EXHIBIT GOOD GROWTH.
MARGIN INCREASE BECAUSE OF DEVICES BIZ.
ZERO BORROWING.
STRONG & RELIABLE MANAGEMENT.
FAMILY OF HSUEH HOLDED 67.67%.
TWO BIG LISTED CAMPANIES SCOMNET'S 大客户 , EDWARDS LIFE SCIENCE AND AMBU.
刚刚签下不久的另一个大客户，MERMAID MEDICAL，再大大刺激订单，FY2020-FY2021 ！
（独家分销商！）
转至主板可能性非常高！
现金高达RM50 mil ！
零负债！没贷款！
赚副预计从15%至18%！
预料2026年里，心血管设备市场规模会达USD 822 亿！！！
全球由5个主要商参与，其中一个就是SCOMNET的大客户！
FY2020 净利料RM28mil， FY2021 净利RM35 mil！
ON TRACK TO DELIVER RECORD EARNINGS WITH ACCELERATED GROWTH IN EPS OF 59% IN FY2020 & 41% IN fy2021.
STRONG GROWTH CAGR 30%!
Stock
2020-09-01 20:47 | Report Abuse
WHY WE LOOK INTO SCOMNET ?
CASH FLOW STRONG.
MEDICAL DIVICE INDUSTRY WILL CONTINUE TO EXHIBIT GOOD GROWTH.
MARGIN INCREASE BECAUSE OF DEVICES BIZ.
ZERO BORROWING.
STRONG & RELIABLE MANAGEMENT.
FAMILY OF HSUEH HOLDED 67.67%.
TWO BIG LISTED CAMPANIES SCOMNET'S 大客户 , EDWARDS LIFE SCIENCE AND AMBU.
刚刚签下不久的另一个大客户，MERMAID MEDICAL，再大大刺激订单，FY2020-FY2021 ！
（独家分销商！）
转至主板可能性非常高！
现金高达RM50 mil ！
零负债！没贷款！
赚副预计从15%至18%！
预料2026年里，心血管设备市场规模会达USD 822 亿！！！
全球由5个主要商参与，其中一个就是SCOMNET的大客户！
FY2020 净利料RM28mil， FY2021 净利RM35 mil！
ON TRACK TO DELIVER RECORD EARNINGS WITH ACCELERATED GROWTH IN EPS OF 59% IN FY2020 & 41% IN fy2021.
STRONG GROWTH CAGR 30%!
Stock
2020-09-01 20:46 | Report Abuse
WHY WE LOOK INTO SCOMNET ?
CASH FLOW STRONG.
MEDICAL DIVICE INDUSTRY WILL CONTINUE TO EXHIBIT GOOD GROWTH.
MARGIN INCREASE BECAUSE OF DEVICES BIZ.
ZERO BORROWING.
STRONG & RELIABLE MANAGEMENT.
FAMILY OF HSUEH HOLDED 67.67%.
TWO BIG LISTED CAMPANIES SCOMNET'S 大客户 , EDWARDS LIFE SCIENCE AND AMBU.
刚刚签下不久的另一个大客户，MERMAID MEDICAL，再大大刺激订单，FY2020-FY2021 ！
（独家分销商！）
转至主板可能性非常高！
现金高达RM50 mil ！
零负债！没贷款！
赚副预计从15%至18%！
预料2026年里，心血管设备市场规模会达USD 822 亿！！！
全球由5个主要商参与，其中一个就是SCOMNET的大客户！
FY2020 净利料RM28mil， FY2021 净利RM35 mil！
ON TRACK TO DELIVER RECORD EARNINGS WITH ACCELERATED GROWTH IN EPS OF 59% IN FY2020 & 41% IN fy2021.
STRONG GROWTH CAGR 30%!
Stock
Stock
2020-09-01 20:39 | Report Abuse
当年的July 2013 ，EASTLAND曾经是RM1.00多的股。
Stock
2020-09-01 20:37 | Report Abuse
EastLand Equity Bhd is a Malaysian based investment holding company. The business activity of the firm is operated in leasing and financing, hospitality business, investment properties and property development division. Its portfolio includes project development in Kelantan, Renaissance Kota Bharu Hotel, and shopping complex and condominium. All the activities are functioned through the region of Malaysian.
Stock
Stock
Stock
Stock
2020-08-29 11:30 | Report Abuse
在这事件上，我不去怪Hoh 13。
最重要的还是还大家一个事实。
活在世上，人应该和人讲人话。
Stock
2020-08-29 11:22 | Report Abuse
谢谢你，stockintalk.
替我解围，同时也替Scib 忠心 shareholders解围。
Stock
2020-08-29 08:20 | Report Abuse
Pernahkah kalian hadapi situasi seperti:
Lepas lepas tickets, baru bullish?
I faced this situation before.
Stock
2020-08-29 07:22 | Report Abuse
Dnonce会脱离penny stock 身份。
RM1.00 是迟早的事.
Stock
2020-08-29 07:02 | Report Abuse
Morning ☀️.
As I know, Serbadk hit almost RM5.00 before ex-date of Bonus Issue and Stock Split exercise.
Stock
2020-08-25 08:55 | Report Abuse
ESOS mean good prospect for company.
公司前景不美好就不会作ESOS了。
Stock
2020-08-25 08:25 | Report Abuse
有一些上市公司，有为员工们每一个月从薪水扣除几百块来以比较低的价位买入/存入该公司股票。其中一个公司就是Hartalega.
这与ESOS 有点相同。
Stock
2020-08-25 08:10 | Report Abuse
DNONCE TECHNOLOGY Key Highlights
• Significant improvement in Profit Before Tax (“PBT”) from loss of RM3.34 million in 1H Year-to-date (“YTD”) 30 June 2019 to RM2.40 million, an increase of RM5.74 million or 172% for Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
• Noteworthy surge in revenue, average monthly sales for July 2019 till April 2020 was RM14.6 million compared with January 2019 till June 2019 of RM13.3 million representing a 9.8% increase, even though March and April sales were impacted by the Covid-19 induced MCO
• Three consecutive profitable quarters with FYE PBT of RM2.40 million signifying 9 straight months of profit until April since the new management took over the running of the Company.
D’nonce Technology Bhd (“D’nonce” or “the Group”) (“7114”), today announced its interim financial results for the sixth quarter (“Q6”) and 16-month consolidated financial results for its Financial Year Ended 30 April 2020 (“FYE 30 April 2020”).
DNONCE is a diversified engineering solutions provider, serving customers in the semiconductor, automotive, medical/healthcare, data storage hardware and consumer electronics industries with overseas subsidiaries in Thailand.
In mid-July 2019, D’nonce had installed a new Board of Directors and management, led by Mr. Tho Yow Yin as CEO. Under the new leadership.
DNONCE embarked on costcutting measures and redirected their focus to expand the Group’s growth in value-added businesses. These efforts have borne positive results as reflected in its financial performance since July 2019 to 30 April 2020.
D’nonce recorded a revenue of RM225 million for the FYE 30 April 2020, of which from 1 July 2019 to 30 April 2020, the Group recorded an average monthly revenue of RM14.6 million as compared to an average monthly revenue of RM13.3 million from 1 January 2019 to 30 June 2019, representing a 9.8% improvement in sales, despite the MCO which impacted operations in March and April 2020.
The significant increment of the revenue was partly contributed by the surge in demand from customers in the healthcare industry mainly due to the Covid-19 outbreak as D’nonce provides essential support to the glove industry in Southern Thailand and also supplies injection molded ventilator parts from their factory in Prai, Pulau Pinang.
Simultaneously, DNONCE continued to showcase a healthy and growing PBT having recorded a PBT of RM2.40 million for the Financial Period Ended 30 April 2020 reflecting a turnaround of RM5.74 million or 172% growth over the 1H Loss Before Tax of RM3.34 million. With the exception of Q6 FY2020 (which consisted of only 1 month), the Group achieved three consecutive quarters in the black (cumulative PBT of RM5.74 million from 1 July 2019 to 30 April 2020) - after losses earlier in the financial year throughout the first two quarters (cumulative Loss Before Tax of RM3.34 million from 1 January 2019 to 30 June 2019).
This is the result of the DNONCE Management’s continuous prudence in managing its expenses while expanding revenue, resulting in the highest level of operational efficiency and also the continuous growth of its business.
As of 30th April 2020 the Group has generated a positive cash flow of RM8.16 million from operating activities and have cash and bank balances of RM32.5 million. For the full FYE 30 April 2020, D’nonce recorded a Profit After Tax of RM0.73 million (after the non-cash adjustment from the revaluation of properties deficit of RM0.45 million) in spite of the net losses recorded for Financial Period Ended 30 June 2019.
Notwithstanding the challenging environment, DNONCE is cautiously optimistic of its business with the expectation of continued strong demand for its supplies to the medical and health sectors as well as the positive demand from the electronic technology sector moving forward.
DNONCE has active initiatives underway to enhance its overall organisational effectiveness.
These initiatives should increase productivity and cost efficiency while also helping to realise scale economies as Dnonce continues to grow its commercial opportunities.
两大利好围绕DNONCE！！
1）Provides Essential Support (Glove Industry) Southern Thailand
2） Injection Molded Ventilator Parts (Prai, Pulau Pinang)
预料，DNONCE 可突破
---------RM1.00----------大关。
Stock
Stock
2020-08-25 07:32 | Report Abuse
Your TP rm6.50 Only For Financial Year of 2020, after Share split or Bonus Issue exercise, will be new TP for FY2021.
Stock
2020-08-23 18:05 | Report Abuse
只是怕一开始就冲突30 sen 而已，就错过了26-26.5 sen了。
Stock
2020-08-23 17:29 | Report Abuse
Open price on Monday, if able to buy 26-26.5 sen, I will just accumulate without thinking this and that. Pray for me.
Stock
2020-08-23 15:03 | Report Abuse
Who can tell me, SCIB orderbook stand at RM1.5 billion or RM1.7 billion ?
Stock
2020-08-23 13:19 | Report Abuse
Tomorrow Monday, ISTONE to trade RM0.265-RM0.275 likely.
Stock
Stock
Stock
Stock
Stock
Stock
Stock
Stock
Stock
2020-08-08 20:54 | Report Abuse
总而言之，一句话，买入具有长期性成长股。
还没发生Covid19, Topglov, Supermax, Kossan, Hartalega 他们都是具有长期性成长股。CAREPLS 也一样，只是，很年轻，它具有很大的成长空间。
Stock
Stock
2020-08-08 17:10 | Report Abuse
Remember, another thing is that before Covid19 , 手套股行业已经很赚钱了的。
Stock
2020-08-08 17:08 | Report Abuse
Who has Invested Harta since 2008 at minimum RM1000？
In 2020, we only count RM12.00, the minimum RM 1000 today valued RM88,000.
Who has Invested HARTA since 2008?
Stock
2020-08-06 10:05 | Report Abuse
Carepls 的EPS per Quarter 与Supermax EPS per Quarter 几乎像同。分别只是在于他们两者的股数。
Supermax 股数：13.6亿张。
Carepls 股数： 540.36 mil (5.4034 亿张而已）
Stock
Stock: [SCIB]: SARAWAK CONSOLIDATED IND BHD
2020-09-05 16:47 | Report Abuse
以往马来西亚高股息股已不再是人们口头上称的高股息股了，很多都开始卖出，进入一些强劲现金流+受看好未来净利股。
在我言里，Sarawak Consolidated Industries Bhd（SCIB) PRICE TARGET RM6.50 before Bonus Issue ex-date.